Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene-Specific Endothelial Programs Drive AVM Pathogenesis in <i>SMAD4</i> and <i>ALK1</i> Loss-of-Function.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Real-World Evidence for Expanding the Criteria for Endoscopic Resection in Submucosal Gastric Cancer: The Role of Invasion Width.

Journal of gastric cancer·2026
Same author

Astrocytic ankyrin-2 enables memory persistence in the mouse hippocampus.

Nature communications·2026
Same author

Plasminogen Activator Inhibitor-1 is Internalized by Endothelial Cells via A Pinocytosis-Like Mechanism and Evades Degradation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Dynapenic metabolic syndrome phenotypes and depression in older adults: A nationwide population-based study.

Journal of psychosomatic research·2026
Same author

CaMKII-based gene therapy protects retinal ganglion cells in a broad range of disease: ischemic retinopathy and congenital glaucoma.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Related Experiment Video

Updated: Jan 12, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

14.8K

Restoring compromised blood-retina-barrier integrity with Netrin-1 overexpression.

Jessica Furtado1,2, Thomas E Zapadka1,3, Hyojin Park2

  • 1Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, 06511, USA.

Cellular and Molecular Life Sciences : CMLS
|November 6, 2025
PubMed
Summary

Netrin-1 (NTN1) stabilizes the blood-retina barrier (BRB), crucial for vision. Enhancing NTN1 signaling shows therapeutic potential for preventing vision loss in retinal diseases like diabetic retinopathy (DR).

Keywords:
Age-related macular degeneration (AMD)Blood-retina-barrier (BRB)Diabetic retinopathy (DR)Netrin-1

More Related Videos

An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
09:33

An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment

Published on: September 13, 2016

7.5K
Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

4.5K

Related Experiment Videos

Last Updated: Jan 12, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

14.8K
An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
09:33

An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment

Published on: September 13, 2016

7.5K
Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

4.5K

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Neuroscience

Background:

  • The blood-retina barrier (BRB) is vital for retinal function, and its compromise causes vision-threatening diseases like diabetic retinopathy (DR) and age-related macular degeneration (AMD).
  • Reduced Netrin-1 (NTN1) signaling is observed in DR patients, suggesting NTN1 as a potential therapeutic target to maintain BRB integrity.

Purpose of the Study:

  • To investigate the effects of Netrin-1 (NTN1) overexpression on the development and maintenance of the blood-retina barrier (BRB).
  • To evaluate NTN1's therapeutic potential in preclinical models of retinal vascular diseases.

Main Methods:

  • Utilized inducible genetic overexpression of Netrin-1 (NTN1) in mouse models.
  • Assessed BRB integrity, vascular leakage, and retinal angiogenesis in oxygen-induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) models.
  • Examined the role of Unc5b in Netrin-1 signaling pathways.

Main Results:

  • Global NTN1 overexpression converted leaky angiogenic vessels to a non-leaky state.
  • NTN1 overexpression reinforced BRB integrity in OIR and rescued vascular leak in CNV models, improving electroretinogram (ERG) amplitudes.
  • NTN1 manipulation had minimal impact on retinal angiogenesis, while Unc5b deletion phenocopied vascular leak.

Conclusions:

  • Netrin-1 (NTN1) is a promising therapeutic target for stabilizing the blood-retina barrier (BRB) and preventing vision loss in retinal vascular diseases.
  • Reinforcing the Netrin-1/Unc5b signaling pathway offers a strategy for selective BRB stabilization.